YSB

YSB FCF/Debt

The Free Cash Flow to Debt Ratio of YSB (9885.HK) as of Nov 1, 2026 is 189.18 %. In the previous year, Free Cash Flow to Debt Ratio was 270.84 % — a change of -30.15% (lower).

FCF/Debt

189.18 %

YoY

-30.15%

Last updated:

Free Cash Flow to Debt Ratio of YSB is 2025 189.18 % . Free Cash Flow to Debt Ratio of YSB was 2024 270.84 % . It decreases by -30.15% lower compared to the previous year.

The YSB FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2020
-70.17 CNY
Jan 1, 2021
-389.64 CNY
Jan 1, 2022
30.19 CNY
Jan 1, 2023
206.84 CNY
Jan 1, 2024
270.84 CNY
Jan 1, 2025
189.18 CNY
The YSB FCF/Debt history
YEARFCF/DebtYoY
189.18 %-30.15%
270.84 %+30.95%
206.84 %+585.14%
30.19 %-107.75%
-389.64 %+455.31%
-70.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB, Inc. generates revenue through the wholesale and retail of pharmaceuticals and healthcare products via offline and online platforms. The company operates an online platform enabling pharmaceutical distributors to sell their products, while also offering software-as-a-service (SaaS) solutions to pharmacies. Additionally, YSB sells smart unmanned pharmaceutical booths to third-party pharmacies and provides maintenance and technical support services for these booths. The firm's primary market is domestic, serving pharmacies, distributors, and primary medical institutions through its SaaS and testing services. The company's SaaS solutions target pharmacies, helping them manage operations, while the smart unmanned pharmaceutical booths are sold to third-party pharmacies for retail distribution. Medical testing services are provided directly to primary medical institutions, and the firm's online platform connects distributors with buyers. All services and products are focused on the domestic market, with no international operations mentioned in the description. YSB, Inc. makes money by selling pharmaceuticals and healthcare products through its platforms, offering SaaS to pharmacies, and providing maintenance services for smart booths. The firm's revenue streams include direct sales of products, SaaS subscriptions, booth sales, and technical support contracts. Primary customers are pharmacies, distributors, and primary medical institutions, all operating within China's domestic market. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

Free Cash Flow to Debt Ratio of YSB is 189.18 % in 2025.

Free Cash Flow to Debt Ratio of YSB changed from 270.84 % to 189.18 %, representing a -30.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio YSB since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's YSB with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — YSB

All Key Metrics — YSB